3 stories mentioning SHA:688366Updated 17d ago
Every FINWIRES story that references SHA:688366, newest first.
China's drug administrator approved Shanghai Haohai Biological Technology (SHA:688366) subsidiary Henan Saimei Vision Biotechnology's trifocal intraocular lens.The product is indicated for vision correction in adult cataract patients and helps improve, near, intermediate, and far vision, according to a Wednesday filing with the Shanghai bourse.
Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) said Chairman Hou Yongtai resigned effective Friday, due to age, according to a same-day filing with the Hong Kong bourse.Hou will continue to hold positions in certain subsidiaries and will be appointed chief scientific advisor of the company.The company named General Manager Wu Jianying as chairman, effective the same day.
Shanghai Haohai Biological Technology (SHA:688366, HKG:6826) reported an attributable profit of 73.6 million yuan for the first quarter of 2026, down 19% from 90.3 million yuan in the year-ago period, according to a Hong Kong bourse filing on Friday.Hong Kong-listed shares of the ophthalmic products manufacturer were up nearly 2% in late morning trading on Monday.Earnings per share were 0.32 yuan, compared with 0.39 yuan in the prior year.Revenue fell 7.6% year on year to 571.4 million yuan, figures showed.
